| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/08/2005 | EP1097174B1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 06/08/2005 | EP1092017A4 Novel gaba-b receptor |
| 06/08/2005 | EP0997152B1 Antibodies as REMEDIES FOR LYMPHOCYTIC TUMORS (EXCEPT MYELOMA) |
| 06/08/2005 | EP0850252B1 Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | CN1625567A Novel monoclonal antibody and nematode larval antigens |
| 06/08/2005 | CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| 06/08/2005 | CN1624128A Death domain containing receptor 5 antibodies |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1624115A Cell surface molecule mediating cell adhesion and signal transmission |
| 06/08/2005 | CN1624000A Alpha fetoprotein receptor, its multiclone antibody, kit and application thereof |
| 06/08/2005 | CN1205225C Human protein with cancer inhibiting function and its coding sequence |
| 06/07/2005 | US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903195 Obtaining a cell sample, lysing or permeabilizing the cells to antibodies, adding antibody to the cell sample, complexing antibody with CDN-1(a protein) and detecting the CDN protein |
| 06/07/2005 | US6903194 Antibody against human parathormone related peptides |
| 06/07/2005 | US6903190 Nematode ATP synthase subunit E-like sequences |
| 06/07/2005 | US6902930 Human Mob-5 (IL-24) receptors and uses thereof |
| 06/07/2005 | US6902926 For production of vaccines; fusion proteins |
| 06/07/2005 | US6902922 Subtilisin variants |
| 06/07/2005 | US6902921 Genetically engineered adenosine triphosphate generating polypeptide; sequences determination; reporter molecules |
| 06/07/2005 | US6902910 Death domain containing receptor 4 |
| 06/07/2005 | US6902907 Cystic fibrosis gene |
| 06/07/2005 | US6902890 Method of diagnosing monitoring, staging, imaging and treating cancer |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | US6902734 Also an IL-12 anti-idiotype antibody to the antibody |
| 06/07/2005 | CA2348026C Antibodies against semp1, methods for their production and uses thereof |
| 06/07/2005 | CA2153135C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them |
| 06/02/2005 | WO2005050213A1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 06/02/2005 | WO2005050200A2 Screening assays and methods of tumor treatment |
| 06/02/2005 | WO2005050198A2 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 06/02/2005 | WO2005049814A2 Novel atypical pneumonia-causing virus |
| 06/02/2005 | WO2005049802A2 Anti-hydroxylase antibodies and uses thereof |
| 06/02/2005 | WO2005049800A2 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell |
| 06/02/2005 | WO2005049655A1 Leptin antagonist and method for quantitative measurement of leptin |
| 06/02/2005 | WO2005049654A1 ANTI-Kank MONOCLONAL ANTIBODY |
| 06/02/2005 | WO2005049653A1 Affinity separation composition and method |
| 06/02/2005 | WO2005049652A2 Methods of generating antibody diversity in vitro |
| 06/02/2005 | WO2005049651A2 Cancer diagnosis and therapy |
| 06/02/2005 | WO2005049645A1 Recovery of a heat shock protein |
| 06/02/2005 | WO2005049635A2 Human monoclonal antibody having fat-reducing effect |
| 06/02/2005 | WO2005049085A1 Use of soluble complexes to facilitate cell activation |
| 06/02/2005 | WO2005049083A1 Preventive/therapeutic agent for tendon/ligament deterioration |
| 06/02/2005 | WO2005049082A2 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 06/02/2005 | WO2005049075A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 06/02/2005 | WO2005049044A1 Oligo-beta-(1, 3) -glucan and monoclonal antibodies against cancer |
| 06/02/2005 | WO2005048938A2 Anti-pecam therapy for metastasis suppression |
| 06/02/2005 | WO2005048935A2 Methods of modulating immunity |
| 06/02/2005 | WO2005048917A2 Use of epha4 and modulator or epha4 for diagnosis, treatment and prevention of cancer |
| 06/02/2005 | WO2005048822A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 06/02/2005 | WO2005034979A3 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 06/02/2005 | WO2005026325A3 Bivalent targeting of cell surfaces |
| 06/02/2005 | WO2005025615A3 FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY |
| 06/02/2005 | WO2005023856A3 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 06/02/2005 | WO2005018575A3 Estrogen receptor modulators and uses thereof |
| 06/02/2005 | WO2005018413A3 Methods, kits and antibodies for detecting parathyroid hormone |
| 06/02/2005 | WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases |
| 06/02/2005 | WO2004094473A3 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 06/02/2005 | WO2004093908A3 Compositions and methods for the therapy of inflammatory bowel disease |
| 06/02/2005 | WO2004092384A3 Means and methods for diagnosing and treating affective disorders |
| 06/02/2005 | WO2004087058A3 Targeted mhc class i alpha3 vaccine delivery systems |
| 06/02/2005 | WO2004082596A3 Yersinia species compositions |
| 06/02/2005 | WO2004081187A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 06/02/2005 | WO2004075837A3 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 06/02/2005 | WO2004074324A3 Modulation of the poliovirus receptor function |
| 06/02/2005 | WO2004071414A3 Therapeutic anti-hcv (al9) compounds |
| 06/02/2005 | WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 06/02/2005 | WO2004062462A9 Monclonal anitbodies to rna binding protein gw182 |
| 06/02/2005 | WO2004041212A3 Apkc isoforms in nervous system disorders and cancer |
| 06/02/2005 | WO2003090514A3 Adipocyte complement related protein zacrp14 |
| 06/02/2005 | US20050119463 Antibody recognizing proliferative human liver cells proliferative human liver cells and functional human liver cells |
| 06/02/2005 | US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics |
| 06/02/2005 | US20050119457 Human proteins |
| 06/02/2005 | US20050119456 and a monoclonal, humanized, or single-chain antibody specific for the C21 polypeptide; gene overexpression in mouse hematopoeitic cells alters myeloid development and in 3T3 fibroblasts, increases apoptosis resistance |
| 06/02/2005 | US20050119455 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 06/02/2005 | US20050119171 Forsenic analysis; medical diagnosis; chromosome markers |
| 06/02/2005 | US20050118688 Isolating carboxylated glycan for use in prevention and treatment of inflammation and cancer |
| 06/02/2005 | US20050118682 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 06/02/2005 | US20050118660 Using lipoprotein (LP1) specific monoclonal antibody to detect pseudomonas infection; bioassay |
| 06/02/2005 | US20050118658 Use of ERRalpha phosphorylation status as a breast cancer biomarker |
| 06/02/2005 | US20050118654 Hemoglobin assay for neonatal screening |
| 06/02/2005 | US20050118652 Rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
| 06/02/2005 | US20050118651 Immunoglobulin light chain comprising variable complementarity determining regions (CDRs) for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy; immunodiagnostics |
| 06/02/2005 | US20050118645 Prion specific immunogllobulin for detection, diagnosis and prevention of spongiform encephalopathies; immunotherapy |
| 06/02/2005 | US20050118643 Specific binding agents to hepatocyte growth factor |
| 06/02/2005 | US20050118638 Using thyrotrophin (TSH) receptor as diagnostic tool in detection of autoimmune diseases; competive binding assay |
| 06/02/2005 | US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 06/02/2005 | US20050118592 Using allelic variation aristaless homeobox gene (ARX) as diagnostic tool in detection of convulsive and learning disorders |
| 06/02/2005 | US20050118591 Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer |
| 06/02/2005 | US20050118586 Expression vector comprising nucleotide sequences coding heterologous polypeptide for use in forensic analysis as chromosome, tissue, cell and organelle specific markers |
| 06/02/2005 | US20050118579 Using allelic variation in canalicular multispecific organic anion transporter (cMOAT) gene as diagnostic tool in detection of liver and bile duct disorders |
| 06/02/2005 | US20050118575 Immune cell polypeptide for use in diagnosis and treatment of cell proliferative disorders |
| 06/02/2005 | US20050118569 Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to venezuelan equine encephalitis virus |
| 06/02/2005 | US20050118198 Polysaccharide vaccine for staphylococcal infections |
| 06/02/2005 | US20050118197 Given repeating trisaccharide unit of mannose units; polysaccharide-protein conjugates useful in diagnosis of or vaccination against H pyroli |
| 06/02/2005 | US20050118195 Virus causing respiratory tract illness in susceptible mammals |
| 06/02/2005 | US20050118190 Staphylococcus antigen and vaccine |
| 06/02/2005 | US20050118185 of an extracellular antigen binding domain (scFv) and a transmembrane region derived from the CD3 zeta-chain and/or the Fc epsilon RI gamma-chain linked to an intracellular signaling domain with cell activation properties; use in e.g. adoptive immunotherapy |
| 06/02/2005 | US20050118183 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 06/02/2005 | US20050118182 Conjugated to radioisotope, drug, cyotoxic agent or biodrug; immunotoxin of use to treat cancer; immunoassay kit for detection of CD 22+ cancer cells |